Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Insulin aspart by Amphastar Pharmaceuticals for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin aspart is under clinical development by Amphastar Pharmaceuticals and currently in Pre-Registration for Type 1 Diabetes (Juvenile Diabetes). According...
Data Insights
Insulin aspart by Amphastar Pharmaceuticals for Type 2 Diabetes: Likelihood of Approval
Insulin aspart is under clinical development by Amphastar Pharmaceuticals and currently in Pre-Registration for Type 2 Diabetes. According to GlobalData,...